Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.235 CHF
−83.02 M CHF
203.89 M CHF
52.65 M
About PROCEPT BioRobotics Corporation
Sector
Industry
CEO
Larry L. Wood
Website
Headquarters
San Jose
Founded
2007
ISIN
US74276L1052
FIGI
BBG01TNYZMV4
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of PRCT is 28.526 CHF — it has increased by 4.16% in the past 24 hours. Watch PROCEPT BioRobotics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange PROCEPT BioRobotics Corp. stocks are traded under the ticker PRCT.
PRCT stock has risen by 4.16% compared to the previous week, the month change is a 4.16% rise, over the last year PROCEPT BioRobotics Corp. has showed a 4.16% increase.
We've gathered analysts' opinions on PROCEPT BioRobotics Corp. future price: according to them, PRCT price has a max estimate of 67.67 CHF and a min estimate of 39.81 CHF. Watch PRCT chart and read a more detailed PROCEPT BioRobotics Corp. stock forecast: see what analysts think of PROCEPT BioRobotics Corp. and suggest that you do with its stocks.
PRCT reached its all-time high on Oct 30, 2025 with the price of 28.526 CHF, and its all-time low was 27.387 CHF and was reached on Oct 16, 2025. View more price dynamics on PRCT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PRCT stock is 3.99% volatile and has beta coefficient of 0.78. Track PROCEPT BioRobotics Corp. stock price on the chart and check out the list of the most volatile stocks — is PROCEPT BioRobotics Corp. there?
Today PROCEPT BioRobotics Corp. has the market capitalization of 1.52 B, it has increased by 2.40% over the last week.
Yes, you can track PROCEPT BioRobotics Corp. financials in yearly and quarterly reports right on TradingView.
PROCEPT BioRobotics Corp. is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
PRCT earnings for the last quarter are −0.28 CHF per share, whereas the estimation was −0.33 CHF resulting in a 15.66% surprise. The estimated earnings for the next quarter are −0.33 CHF per share. See more details about PROCEPT BioRobotics Corp. earnings.
PROCEPT BioRobotics Corp. revenue for the last quarter amounts to 62.82 M CHF, despite the estimated figure of 61.08 M CHF. In the next quarter, revenue is expected to reach 64.39 M CHF.
PRCT net income for the last quarter is −15.53 M CHF, while the quarter before that showed −21.90 M CHF of net income which accounts for 29.07% change. Track more PROCEPT BioRobotics Corp. financial stats to get the full picture.
No, PRCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2025, the company has 756 employees. See our rating of the largest employees — is PROCEPT BioRobotics Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROCEPT BioRobotics Corp. EBITDA is −68.17 M CHF, and current EBITDA margin is −40.70%. See more stats in PROCEPT BioRobotics Corp. financial statements.
Like other stocks, PRCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROCEPT BioRobotics Corp. stock right from TradingView charts — choose your broker and connect to your account.